6.64 ng/mL) significantly increased at follow-up compared to baseline (all p < 0.05, Wilcoxon matched-pairs signed-rank test), while LDH and CYFRA21-1 exhibited an increasing trend (Supplemental Table S10).
← all excerpts
A serum biomarker-based index for predicting progressive pulmonary fibrosis in patients with anti-synthetase syndrome: the LOCCM index.
1
—
—